Drug Formulation Market Growth Forecast: Market Size, Key Trends And Emerging Opportunities Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Drug Formulation Market CAGR Outlook And Future Development
The drug formulation market size has demonstrated significant expansion in recent years. It is anticipated to expand from $2045.31 billion in 2025 to $2221.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The historical growth within this market can be linked to factors such as an increase in generic drug demand, a rise in the prevalence of chronic diseases, advancements in pharmaceutical research, the expansion of hospital and clinic networks, and growing investments in research and development.
The drug formulation market is projected to experience substantial expansion over the next few years. It is forecast to reach $3196.24 billion by 2030, showing a compound annual growth rate (CAGR) of 9.5%. The expansion during this forecast period can be attributed to the rise of gene and cell therapies, the integration of AI in drug design, the creation of novel excipients, an increase in biologics and specialty drugs, and the growth of emerging pharmaceutical markets. Key trends anticipated during this period include personalized drug formulations, sophisticated drug delivery systems, the development of biologics and biosimilars, efforts to optimize formulation stability and shelf-life, and a focus on regulatory compliance and quality assurance.
Get A Free Sample Report With In-Depth Market Insights:
Drug Formulation Market Growth Backed By Core Demand Fundamentals
The expanding embrace of personalized medicine is anticipated to drive future growth in the drug formulation market. This innovative healthcare strategy customizes medical treatments and interventions according to each patient’s unique attributes. It entails adapting therapies grounded in specific patient traits, including genetic makeup and biomarkers. Such an approach mandates the creation of bespoke drug formulations to maximize effectiveness and safety for every individual patient. Its influence includes demanding individualized treatment regimens, formulations that incorporate genomic understanding, enhanced drug responses, and specially designed treatments for uncommon diseases. As an illustration, data from the Personalized Medicine Coalition (PMC), a US-based non-profit, indicated that personalized medicines constituted around 38 percent of all newly approved therapeutic molecular entities in 2023, an increase from 34 percent in 2022. Consequently, the rising prevalence of personalized medicine is fueling the expansion of the drug formulation market.
Drug Formulation Market Segmentation And Category Overview
The drug formulation market covered in this report is segmented –
1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations
2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations
3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases
4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies
Subsegments:
1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions
2) By Parenteral Formulations: Injectables, Implants, Infusions
3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches
4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
Drug Formulation Market Growth Trends Reshaping The Competitive Landscape
Major companies in the drug formulation market are developing new fixed dose combination drugs for type 2 diabetes to gain a competitive edge. A Fixed Dose Combination (FDC) is a pharmaceutical formulation containing two or more active ingredients combined in a fixed ratio of doses within a single dosage form. For instance, in October 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched its first triple-drug fixed-dose combination under the brand name Zita DM. It includes the DPP4 inhibitor, Teneligliptin (20mg), the SGLT2 inhibitor, Dapagliflozin (10mg), and Metformin SR (500mg/1000mg) in a fixed dose. This medication must be taken once daily, under prescription, to improve glycemic control in patients with Type 2 diabetes.
Drug Formulation Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc
View The Full Drug Formulation Market Report:
Drug Formulation Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the drug formulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
